May 1st 2025
Self-paying patients can now obtain semaglutide at a lower cost through trusted telehealth providers.
Formulary Considerations: The Past, Present, and Future
October 16th 2017The hospital formulary system is an ongoing process that evaluates and selects the safest, most effective, and most economical care for hospitalized patients. As healthcare continues to change, so will the formulary management process.
Read More
With the clinical and financial implications of high-cost medications, and their impact on health system revenue, it is of utmost importance for all key stakeholders to be engaged in the complex revenue cycle.
Read More
Patients With Diabetes Hospitalized Less When Enrolled in Special Needs Plans
October 12th 2017Specialized Medicare Advantage plans called chronic condition special needs plans (C-SNPs), may demonstrate greater improvement in outcomes and utilization of care for the beneficiaries when compared to non-SNP Medicare plans, according to a new analysis from Avalere Health.
Read More
Association Between FDA Black Box Warnings and Medicare Formulary Coverage Changes
Medicare formularies were inconsistent in increasing restrictiveness to drugs that received FDA black box warnings for death and/or cardiovascular risk with safer available drug alternatives.
Read More
How Concierge Care for Low-Income Seniors Can Improve Outcomes and Reduce Costs
September 26th 2017While little seems certain about the current healthcare reform debate in Congress, the transition to value-based care is well underway. We are beginning to see that when providers are paid to deliver better care at lower costs, they can have a real impact on both.
Read More
This Week in Managed Care: September 22, 2017
September 22nd 2017This week, the top managed care stories included a new direction for the Center for Medicare and Medicaid Innovation; a bipartisan group of governors spoke out against the latest effort to repeal the Affordable Care Act; and the World Health Organization warned that antibiotics currently being developed were not enough to fight antibiotic-resistant infections.
Watch
Amanda Forys on How Medicare Will Refine Its Biosimilar Policy
September 14th 2017Amanda Forys, MSPH, director of Xcenda’s Reimbursement Policy Insights consulting team, discusses how Medicare will address and possibly change its biosimilar policies as the FDA offers more guidance and as biosimilars become more prevalent in the market.
Watch
Geographic Variation in Medicare and the Military Healthcare System
Geographic variation in healthcare spending and utilization within the Military Health System is higher and significantly correlated with Medicare across hospital referral regions.
Read More
Impact of Formulary Restrictions on Medication Use and Costs
Placing formulary restrictions on brand name drugs shifts use toward generics, lowers the cost per prescription fill, and has minimal impact on overall adherence for antidiabetes, antihyperlipidemia, and antihypertension medications among low-income subsidy recipients in Medicare Part D plans.
Read More
Study: Dexcom CGM Benefits Type 2 Diabetes Patients Using Multiple Daily Insulin Injections
August 21st 2017To avoid bias, the study did use aggressive titration protocols that might be found in a real-world setting. Still, patients using CGM saw greater reductions in A1C and more time in range.
Read More